Predictors for Chemotherapy Tolerance and Toxicity in Elderly Cancer Patients

Predictors for Chemotherapy Tolerance and Toxicity in Elderly Cancer Patients - P-TOP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39958

Enrollment

120

Registered

2012-10-25

Start date

2012-11-29

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy tolerance toxicity

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with a metastasized malignancy that will be treated with palliative chemotherapy. - Patients with a non hogdkin lymphoma or a multiple myeloma that will be treated with chemotherapy - Patients that are at least 70 years old at start of chemotherapy. - Informed consent.

Exclusion criteria

Exclusion criteria: - Patients who have unadequate command of the Dutch language. - Patients who are cognitive impaired. - Patients with CNS metastases.

Design outcomes

Primary

Measure	Time frame
Primary outcome is chemotherapy tolerance, defined as the ability to complete the first three cycles. This will then be correlated to the scores from the questionnaires.	—

Secondary

Measure	Time frame
Secondary outcome is (CTCAE graded) toxicity. This will then be correlated to the scores from the questionnaires.	—

Countries

Netherlands

Outcome results